カテゴリ： 世界, 医療/バイオ, Market Monitor Global

OTC片頭痛薬のグローバル市場展望 2023年-2029年：NSAIDs、アセトアミノフェン、その他

■ 英語タイトル：OTC Migraine Medicine Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC16512）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC16512
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：64
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[OTC片頭痛薬のグローバル市場展望 2023年-2029年：NSAIDs、アセトアミノフェン、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のOTC片頭痛薬市場規模と予測を収録しています。・世界のOTC片頭痛薬市場：売上、2018年-2023年、2024年-2029年
・世界のOTC片頭痛薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のOTC片頭痛薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「NSAIDs」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

OTC片頭痛薬のグローバル主要企業は、Johnson & Johnson、 GSK、 Bayer、 Haleon、 Tongde Pharmacy、 Huazhong Pharmaceutical、 Weisen Pharmaceutical、 DIAO GROUP、 Jiheng Pharmaceutical、 Dirui Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、OTC片頭痛薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のOTC片頭痛薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のOTC片頭痛薬市場：タイプ別市場シェア、2022年
・NSAIDs、アセトアミノフェン、その他

世界のOTC片頭痛薬市場：用途別、2018年-2023年、2024年-2029年
世界のOTC片頭痛薬市場：用途別市場シェア、2022年
・ドラッグストア、病院

世界のOTC片頭痛薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のOTC片頭痛薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるOTC片頭痛薬のグローバル売上、2018年-2023年
・主要企業におけるOTC片頭痛薬のグローバル売上シェア、2022年
・主要企業におけるOTC片頭痛薬のグローバル販売量、2018年-2023年
・主要企業におけるOTC片頭痛薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Johnson & Johnson、 GSK、 Bayer、 Haleon、 Tongde Pharmacy、 Huazhong Pharmaceutical、 Weisen Pharmaceutical、 DIAO GROUP、 Jiheng Pharmaceutical、 Dirui Pharmaceutical

*************************************************************

・調査・分析レポートの概要
OTC片頭痛薬市場の定義
市場セグメント
世界のOTC片頭痛薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のOTC片頭痛薬市場規模
世界のOTC片頭痛薬市場規模：2022年 VS 2029年
世界のOTC片頭痛薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのOTC片頭痛薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のOTC片頭痛薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：NSAIDs、アセトアミノフェン、その他
OTC片頭痛薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：ドラッグストア、病院
OTC片頭痛薬の用途別グローバル売上・予測

・地域別市場分析
地域別OTC片頭痛薬市場規模 2022年と2029年
地域別OTC片頭痛薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Johnson & Johnson、 GSK、 Bayer、 Haleon、 Tongde Pharmacy、 Huazhong Pharmaceutical、 Weisen Pharmaceutical、 DIAO GROUP、 Jiheng Pharmaceutical、 Dirui Pharmaceutical
...

This research report provides a comprehensive analysis of the OTC Migraine Medicine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global OTC Migraine Medicine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of OTC Migraine Medicine, challenges faced by the industry, and potential opportunities for market players.
The global OTC Migraine Medicine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The OTC Migraine Medicine market presents opportunities for various stakeholders, including Drug Stores, Hospitals. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in OTC Migraine Medicine market. Additionally, the growing consumer demand present avenues for market expansion.
The global OTC Migraine Medicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
One of the primary market drivers for headache medicine is the high prevalence of headaches and migraines among the global population. Headaches are one of the most common medical complaints, affecting a significant number of individuals across different age groups and demographics. Migraines, in particular, can be debilitating and significantly impact a person’s quality of life, leading to a higher demand for effective headache medications. Additionally, the increasing awareness and understanding of headaches and migraines have contributed to the growth of the headache medicine market. As people become more informed about these conditions and their treatment options, they are more likely to seek medical help and utilize headache medications.
Key Features:
The research report on the OTC Migraine Medicine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the OTC Migraine Medicine market.
Market Overview: The report provides a comprehensive overview of the OTC Migraine Medicine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., NSAIDs, Acetaminophen), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the OTC Migraine Medicine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the OTC Migraine Medicine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the OTC Migraine Medicine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the OTC Migraine Medicine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the OTC Migraine Medicine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the OTC Migraine Medicine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for OTC Migraine Medicine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the OTC Migraine Medicine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
OTC Migraine Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
NSAIDs
Acetaminophen
Others
Market segment by Application
Drug Stores
Hospitals
Global OTC Migraine Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Johnson & Johnson
GSK
Bayer
Haleon
Tongde Pharmacy
Huazhong Pharmaceutical
Weisen Pharmaceutical
DIAO GROUP
Jiheng Pharmaceutical
Dirui Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of OTC Migraine Medicine, market overview.
Chapter 2: Global OTC Migraine Medicine market size in revenue.
Chapter 3: Detailed analysis of OTC Migraine Medicine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of OTC Migraine Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 OTC Migraine Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global OTC Migraine Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global OTC Migraine Medicine Overall Market Size
2.1 Global OTC Migraine Medicine Market Size: 2022 VS 2029
2.2 Global OTC Migraine Medicine Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top OTC Migraine Medicine Players in Global Market
3.2 Top Global OTC Migraine Medicine Companies Ranked by Revenue
3.3 Global OTC Migraine Medicine Revenue by Companies
3.4 Top 3 and Top 5 OTC Migraine Medicine Companies in Global Market, by Revenue in 2022
3.5 Global Companies OTC Migraine Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 OTC Migraine Medicine Players in Global Market
3.6.1 List of Global Tier 1 OTC Migraine Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 OTC Migraine Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global OTC Migraine Medicine Market Size Markets, 2022 & 2029
4.1.2 NSAIDs
4.1.3 Acetaminophen
4.1.4 Others
4.2 By Type – Global OTC Migraine Medicine Revenue & Forecasts
4.2.1 By Type – Global OTC Migraine Medicine Revenue, 2018-2023
4.2.2 By Type – Global OTC Migraine Medicine Revenue, 2024-2029
4.2.3 By Type – Global OTC Migraine Medicine Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global OTC Migraine Medicine Market Size, 2022 & 2029
5.1.2 Drug Stores
5.1.3 Hospitals
5.2 By Application – Global OTC Migraine Medicine Revenue & Forecasts
5.2.1 By Application – Global OTC Migraine Medicine Revenue, 2018-2023
5.2.2 By Application – Global OTC Migraine Medicine Revenue, 2024-2029
5.2.3 By Application – Global OTC Migraine Medicine Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global OTC Migraine Medicine Market Size, 2022 & 2029
6.2 By Region – Global OTC Migraine Medicine Revenue & Forecasts
6.2.1 By Region – Global OTC Migraine Medicine Revenue, 2018-2023
6.2.2 By Region – Global OTC Migraine Medicine Revenue, 2024-2029
6.2.3 By Region – Global OTC Migraine Medicine Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America OTC Migraine Medicine Revenue, 2018-2029
6.3.2 US OTC Migraine Medicine Market Size, 2018-2029
6.3.3 Canada OTC Migraine Medicine Market Size, 2018-2029
6.3.4 Mexico OTC Migraine Medicine Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe OTC Migraine Medicine Revenue, 2018-2029
6.4.2 Germany OTC Migraine Medicine Market Size, 2018-2029
6.4.3 France OTC Migraine Medicine Market Size, 2018-2029
6.4.4 U.K. OTC Migraine Medicine Market Size, 2018-2029
6.4.5 Italy OTC Migraine Medicine Market Size, 2018-2029
6.4.6 Russia OTC Migraine Medicine Market Size, 2018-2029
6.4.7 Nordic Countries OTC Migraine Medicine Market Size, 2018-2029
6.4.8 Benelux OTC Migraine Medicine Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia OTC Migraine Medicine Revenue, 2018-2029
6.5.2 China OTC Migraine Medicine Market Size, 2018-2029
6.5.3 Japan OTC Migraine Medicine Market Size, 2018-2029
6.5.4 South Korea OTC Migraine Medicine Market Size, 2018-2029
6.5.5 Southeast Asia OTC Migraine Medicine Market Size, 2018-2029
6.5.6 India OTC Migraine Medicine Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America OTC Migraine Medicine Revenue, 2018-2029
6.6.2 Brazil OTC Migraine Medicine Market Size, 2018-2029
6.6.3 Argentina OTC Migraine Medicine Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa OTC Migraine Medicine Revenue, 2018-2029
6.7.2 Turkey OTC Migraine Medicine Market Size, 2018-2029
6.7.3 Israel OTC Migraine Medicine Market Size, 2018-2029
6.7.4 Saudi Arabia OTC Migraine Medicine Market Size, 2018-2029
6.7.5 UAE OTC Migraine Medicine Market Size, 2018-2029
7 OTC Migraine Medicine Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson OTC Migraine Medicine Major Product Offerings
7.1.4 Johnson & Johnson OTC Migraine Medicine Revenue in Global Market (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK OTC Migraine Medicine Major Product Offerings
7.2.4 GSK OTC Migraine Medicine Revenue in Global Market (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer OTC Migraine Medicine Major Product Offerings
7.3.4 Bayer OTC Migraine Medicine Revenue in Global Market (2018-2023)
7.3.5 Bayer Key News & Latest Developments
7.4 Haleon
7.4.1 Haleon Company Summary
7.4.2 Haleon Business Overview
7.4.3 Haleon OTC Migraine Medicine Major Product Offerings
7.4.4 Haleon OTC Migraine Medicine Revenue in Global Market (2018-2023)
7.4.5 Haleon Key News & Latest Developments
7.5 Tongde Pharmacy
7.5.1 Tongde Pharmacy Company Summary
7.5.2 Tongde Pharmacy Business Overview
7.5.3 Tongde Pharmacy OTC Migraine Medicine Major Product Offerings
7.5.4 Tongde Pharmacy OTC Migraine Medicine Revenue in Global Market (2018-2023)
7.5.5 Tongde Pharmacy Key News & Latest Developments
7.6 Huazhong Pharmaceutical
7.6.1 Huazhong Pharmaceutical Company Summary
7.6.2 Huazhong Pharmaceutical Business Overview
7.6.3 Huazhong Pharmaceutical OTC Migraine Medicine Major Product Offerings
7.6.4 Huazhong Pharmaceutical OTC Migraine Medicine Revenue in Global Market (2018-2023)
7.6.5 Huazhong Pharmaceutical Key News & Latest Developments
7.7 Weisen Pharmaceutical
7.7.1 Weisen Pharmaceutical Company Summary
7.7.2 Weisen Pharmaceutical Business Overview
7.7.3 Weisen Pharmaceutical OTC Migraine Medicine Major Product Offerings
7.7.4 Weisen Pharmaceutical OTC Migraine Medicine Revenue in Global Market (2018-2023)
7.7.5 Weisen Pharmaceutical Key News & Latest Developments
7.8 DIAO GROUP
7.8.1 DIAO GROUP Company Summary
7.8.2 DIAO GROUP Business Overview
7.8.3 DIAO GROUP OTC Migraine Medicine Major Product Offerings
7.8.4 DIAO GROUP OTC Migraine Medicine Revenue in Global Market (2018-2023)
7.8.5 DIAO GROUP Key News & Latest Developments
7.9 Jiheng Pharmaceutical
7.9.1 Jiheng Pharmaceutical Company Summary
7.9.2 Jiheng Pharmaceutical Business Overview
7.9.3 Jiheng Pharmaceutical OTC Migraine Medicine Major Product Offerings
7.9.4 Jiheng Pharmaceutical OTC Migraine Medicine Revenue in Global Market (2018-2023)
7.9.5 Jiheng Pharmaceutical Key News & Latest Developments
7.10 Dirui Pharmaceutical
7.10.1 Dirui Pharmaceutical Company Summary
7.10.2 Dirui Pharmaceutical Business Overview
7.10.3 Dirui Pharmaceutical OTC Migraine Medicine Major Product Offerings
7.10.4 Dirui Pharmaceutical OTC Migraine Medicine Revenue in Global Market (2018-2023)
7.10.5 Dirui Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. OTC Migraine Medicine Market Opportunities & Trends in Global Market
Table 2. OTC Migraine Medicine Market Drivers in Global Market
Table 3. OTC Migraine Medicine Market Restraints in Global Market
Table 4. Key Players of OTC Migraine Medicine in Global Market
Table 5. Top OTC Migraine Medicine Players in Global Market, Ranking by Revenue (2022)
Table 6. Global OTC Migraine Medicine Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global OTC Migraine Medicine Revenue Share by Companies, 2018-2023
Table 8. Global Companies OTC Migraine Medicine Product Type
Table 9. List of Global Tier 1 OTC Migraine Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 OTC Migraine Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global OTC Migraine Medicine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - OTC Migraine Medicine Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - OTC Migraine Medicine Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global OTC Migraine Medicine Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - OTC Migraine Medicine Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - OTC Migraine Medicine Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global OTC Migraine Medicine Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global OTC Migraine Medicine Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global OTC Migraine Medicine Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America OTC Migraine Medicine Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America OTC Migraine Medicine Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe OTC Migraine Medicine Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe OTC Migraine Medicine Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia OTC Migraine Medicine Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia OTC Migraine Medicine Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America OTC Migraine Medicine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America OTC Migraine Medicine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa OTC Migraine Medicine Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa OTC Migraine Medicine Revenue, (US$, Mn), 2024-2029
Table 30. Johnson & Johnson Company Summary
Table 31. Johnson & Johnson OTC Migraine Medicine Product Offerings
Table 32. Johnson & Johnson OTC Migraine Medicine Revenue (US$, Mn) & (2018-2023)
Table 33. Johnson & Johnson Key News & Latest Developments
Table 34. GSK Company Summary
Table 35. GSK OTC Migraine Medicine Product Offerings
Table 36. GSK OTC Migraine Medicine Revenue (US$, Mn) & (2018-2023)
Table 37. GSK Key News & Latest Developments
Table 38. Bayer Company Summary
Table 39. Bayer OTC Migraine Medicine Product Offerings
Table 40. Bayer OTC Migraine Medicine Revenue (US$, Mn) & (2018-2023)
Table 41. Bayer Key News & Latest Developments
Table 42. Haleon Company Summary
Table 43. Haleon OTC Migraine Medicine Product Offerings
Table 44. Haleon OTC Migraine Medicine Revenue (US$, Mn) & (2018-2023)
Table 45. Haleon Key News & Latest Developments
Table 46. Tongde Pharmacy Company Summary
Table 47. Tongde Pharmacy OTC Migraine Medicine Product Offerings
Table 48. Tongde Pharmacy OTC Migraine Medicine Revenue (US$, Mn) & (2018-2023)
Table 49. Tongde Pharmacy Key News & Latest Developments
Table 50. Huazhong Pharmaceutical Company Summary
Table 51. Huazhong Pharmaceutical OTC Migraine Medicine Product Offerings
Table 52. Huazhong Pharmaceutical OTC Migraine Medicine Revenue (US$, Mn) & (2018-2023)
Table 53. Huazhong Pharmaceutical Key News & Latest Developments
Table 54. Weisen Pharmaceutical Company Summary
Table 55. Weisen Pharmaceutical OTC Migraine Medicine Product Offerings
Table 56. Weisen Pharmaceutical OTC Migraine Medicine Revenue (US$, Mn) & (2018-2023)
Table 57. Weisen Pharmaceutical Key News & Latest Developments
Table 58. DIAO GROUP Company Summary
Table 59. DIAO GROUP OTC Migraine Medicine Product Offerings
Table 60. DIAO GROUP OTC Migraine Medicine Revenue (US$, Mn) & (2018-2023)
Table 61. DIAO GROUP Key News & Latest Developments
Table 62. Jiheng Pharmaceutical Company Summary
Table 63. Jiheng Pharmaceutical OTC Migraine Medicine Product Offerings
Table 64. Jiheng Pharmaceutical OTC Migraine Medicine Revenue (US$, Mn) & (2018-2023)
Table 65. Jiheng Pharmaceutical Key News & Latest Developments
Table 66. Dirui Pharmaceutical Company Summary
Table 67. Dirui Pharmaceutical OTC Migraine Medicine Product Offerings
Table 68. Dirui Pharmaceutical OTC Migraine Medicine Revenue (US$, Mn) & (2018-2023)
Table 69. Dirui Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. OTC Migraine Medicine Segment by Type in 2022
Figure 2. OTC Migraine Medicine Segment by Application in 2022
Figure 3. Global OTC Migraine Medicine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global OTC Migraine Medicine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global OTC Migraine Medicine Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by OTC Migraine Medicine Revenue in 2022
Figure 8. By Type - Global OTC Migraine Medicine Revenue Market Share, 2018-2029
Figure 9. By Application - Global OTC Migraine Medicine Revenue Market Share, 2018-2029
Figure 10. By Type - Global OTC Migraine Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global OTC Migraine Medicine Revenue Market Share, 2018-2029
Figure 12. By Application - Global OTC Migraine Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global OTC Migraine Medicine Revenue Market Share, 2018-2029
Figure 14. By Region - Global OTC Migraine Medicine Revenue Market Share, 2018-2029
Figure 15. By Country - North America OTC Migraine Medicine Revenue Market Share, 2018-2029
Figure 16. US OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 17. Canada OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe OTC Migraine Medicine Revenue Market Share, 2018-2029
Figure 20. Germany OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 21. France OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 23. Italy OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 24. Russia OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia OTC Migraine Medicine Revenue Market Share, 2018-2029
Figure 28. China OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 29. Japan OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 32. India OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America OTC Migraine Medicine Revenue Market Share, 2018-2029
Figure 34. Brazil OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa OTC Migraine Medicine Revenue Market Share, 2018-2029
Figure 37. Turkey OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 38. Israel OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 40. UAE OTC Migraine Medicine Revenue, (US$, Mn), 2018-2029
Figure 41. Johnson & Johnson OTC Migraine Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GSK OTC Migraine Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bayer OTC Migraine Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Haleon OTC Migraine Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Tongde Pharmacy OTC Migraine Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Huazhong Pharmaceutical OTC Migraine Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Weisen Pharmaceutical OTC Migraine Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. DIAO GROUP OTC Migraine Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Jiheng Pharmaceutical OTC Migraine Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Dirui Pharmaceutical OTC Migraine Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 片頭痛治療薬のグローバル市場展望 2023年-2029年：非ステロイド性抗炎症薬、アセトアミノフェン、トリプタン、その他
  • 片頭痛処方薬のグローバル市場展望 2023年-2029年：スマトリプタン、リザトリプタン、その他
  • 処方片頭痛薬のグローバル市場展望 2023年-2029年：スマトリプタン、リザトリプタン、その他
  • 消費者用ニキビ治療薬のグローバル市場展望 2023年-2029年：OTC、処方薬
  • 内科用縫合糸のグローバル市場展望 2023年-2029年：カットグット、再構成コラーゲン、ポリグリコリド、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC16512 )"OTC片頭痛薬のグローバル市場展望 2023年-2029年：NSAIDs、アセトアミノフェン、その他" (英文：OTC Migraine Medicine Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。